A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...

Yanbo Zhang thinks of himself as a detective — and he’s always working a case. A nutritional epidemiologist who’s currently a postdoctoral fellow at the Albert Einstein College of Medicine, Zhang was ...

Background: The direct conversion of human fibroblasts into induced cardiomyocytes (iCMs) holds great promise for generating mature cardiomyocytes for clinical applications. However, the process ...

A few months after launching its lead gene therapy into the clinic, Arbor Biotechnologies has found a European partner to come along for the ride. Italian pharma Chiesi is fertilizing Arbor’s rare ...

The company is gene editing crops to make our food supply more resilient to climate change. Climate change will make it increasingly difficult to grow crops across many parts of the world. Pairwise is ...

Dr Katy Rezvani reveals groundbreaking insights on enhancing CAR-NK cell therapy's effectiveness against solid tumors through innovative genetic strategies. In an interview with Targeted Oncology, ...

Department of Biochemistry and Molecular Genetics, Northwestern University, Chicago, Illinois 60611, United States Simpson Querrey Center for Epigenetics, Northwestern University, Chicago, Illinois ...

Scientists from Mass General Brigham and the Broad Institute of MIT and Harvard have used CRISPR screens to identify genetic modifications that influence T cell function and survival in cultures and ...

Department of Clinical Laboratory, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, People’s Republic of China School of Laboratory Medicine, North Sichuan Medical College, ...

University of North Carolina Lineberger Comprehensive Cancer Center researchers have developed a "two-in-one" molecule that can simultaneously turn off two notoriously difficult-to-target ...